Jump to:
Michael represents public and private companies in connection with securities offerings, venture capital financings, mergers and acquisitions and other strategic transactions. As part of his practice, he advises clients on securities law compliance and corporate governance matters.
Prior to re-joining Ropes & Gray, Michael worked in-house as corporate and securities counsel for two Boston area biotechnology companies.
Experience
Capital Markets
- Eversource Energy in connection with registered debt offerings, including $650 million in senior notes.
- Blackstone Life Sciences in strategic financing collaborations with Alnylam and Harmony Biosciences.
- US Acute Care Solutions in connection with a Rule 144A placement of secured notes.
- BRP in connection with its repurchase of CDN$350 million subordinate voting shares by means of a cross border tender offer.
- Provention Bio in connection with a $100 million follow on offering and at-the-market offering.
- A global pharmaceutical company in connection with various private placements.
- Viridian Therapeutics, Inc. in connection with a $150 million follow on offering and at-the-market offering.*
- Magenta Therapeutics, Inc. in connection with its interaction with an activist shareholder and successful reverse merger with Dianthus Therapeutics, Inc.*
Emerging Company / Venture Capital
- Proof Diagnostics in connection with preferred stock Series financings.
- Cyteir Therapeutics in connection with a preferred stock Series financing.
- Various other emerging company clients in connection with preferred stock Series financings, convertible note and warrant financings.
*Prior to re-joining Ropes & Gray